Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1366211 | Bioorganic & Medicinal Chemistry Letters | 2007 | 6 Pages |
Abstract
Steps toward the identification of combi-molecules with strong abl tyrosine kinase (TK) inhibitory property and significant DNA damaging potential are described. The optimized combi-molecule 13a was shown to induce approximately twofold stronger abl TK inhibitory activity than Gleevec™ and high levels of DNA damage in chronic myelogenous leukemic cells.
Graphical abstractWe designed and synthesized an optimized combi-molecule that induced approximately twofold stronger abl TK inhibitory activity than Gleevec and high levels of DNA damage in chronic myelogenous leukemic cells (CML).Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Zakaria Rachid, Athanasia Katsoulas, Christopher Williams, Anne-Laure Larroque, James McNamee, Bertrand J. Jean-Claude,